Pulmonary Fibrosis: all 685 studies

Page 2 of 7. Open to participants first (120), then studies with results posted, then the rest; newest registration first within each.

• Cohort of IPF Patients Experiencing an ExacerbationRecruitingNCT04442711
• Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary InvolvementAvailableNCT04432545
• An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth TechnologyRecruitingNCT04304898
• Longitudinal Changes in Serum KL-6 in IPFRecruitingNCT04268485
• Korean Idiopathic Pulmonary Fibrosis RegistryRecruitingNCT04160715
• Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis PatientsRecruitingNCT03535545Phase 1
• Lung and Bone Marrow Transplantation for Lung and Bone Marrow FailureRecruitingNCT03500731Phase 1/2
• The Genetics of Pulmonary FibrosisRecruitingNCT03478553
• Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung DiseaseRecruitingNCT03455686Not applicable
• Controls for Respiratory DiseasesRecruitingNCT03120481
• European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and BiobankRecruitingNCT02852928
• Longitudinal Observational Study on the Course of Cystic Fibrosis Lung Disease in Patients Following Newborn ScreeningRecruitingNCT02270476
• Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With BevasizumabRecruitingNCT01917877Phase 2
• Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes RegistryRecruitingNCT01915511
• Proteogenomic Monitoring and Assessment of Kidney Transplant RecipientsRecruitingNCT01531257
• Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT01088217
• Explanted Lung Tissues With Pulmonary FibrosisRecruitingNCT00515567
• Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)RecruitingNCT00258570
• Role of Genetic Factors in the Development of Lung DiseaseRecruitingNCT00001532
• Clinical and Basic Investigations Into Hermansky-Pudlak SyndromeRecruitingNCT00001456
• Study to Determine Potential for Drug-drug Interactions When Co-administering Deupirfenidone (LYT-100) and NintedanibCompletedNCT06717100Phase 1Results posted
• Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary FibrosisTerminatedNCT06097260Phase 2Results posted
• The Effect of N115 on Coughing in IPF PatientsCompletedNCT06037408Phase 3Results posted
• Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT05938920Phase 2Results posted
• Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) PatientsCompletedNCT05870956Results posted
• A Study in People With Pulmonary Fibrosis to Monitor Cough With a Wearable DeviceCompletedNCT05670587Not applicableResults posted
• First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy SubjectsCompletedNCT05427253Phase 1Results posted
• Controlled Investigation to Evaluate Impact of dCBT on Psychological Symptom Burden in Adult Subjects With PFCompletedNCT05330312Not applicableResults posted
• Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary FibrosisCompletedNCT05130970Phase 2Results posted
• A Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary FibrosisTerminatedNCT05032066Phase 2Results posted
• Adherence to Nintedanib Among Idiopathic Pulmonary Fibrosis PatientsCompletedNCT05022784Results posted
• A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19.TerminatedNCT04880109Phase 2Results posted
• A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease PatientsTerminatedNCT04837131Phase 2Results posted
• LYT-100 in Post-acute COVID-19 Respiratory DiseaseTerminatedNCT04652518Phase 2Results posted
• The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19CompletedNCT04619680Phase 4Results posted
• A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary FibrosisTerminatedNCT04594707Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary FibrosisTerminatedNCT04552899Phase 3Results posted
• Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPFCompletedNCT04533022Phase 2Results posted
• Safety and Effectiveness of Nintedanib in Korean PatientsCompletedNCT04525547Results posted
• Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT04419558Phase 3Results posted
• A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT04419506Phase 2Results posted
• Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary FibrosisCompletedNCT04396756Phase 2Results posted
• A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung FibrosisCompletedNCT04308681Phase 2Results posted
• Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/CompletedNCT04072315Phase 2Results posted
• A Study of Nalbuphine (Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of CoughCompletedNCT04030026Phase 2Results posted
• A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are TakingCompletedNCT03958071Results posted
• Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT03955146Phase 3Results posted
• Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis.CompletedNCT03928847Early Phase 1Results posted
• A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT03832946Phase 2Results posted
• Self-monitoring of Spirometry & Symptoms Via patientMpower App in Idiopathic Pulmonary FibrosisTerminatedNCT03744598Results posted
• A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of CareTerminatedNCT03733444Phase 3Results posted
• Safety, Tolerability, and Pharmacokinetic Study of TRK-250 for Patients With Idiopathic Pulmonary FibrosisCompletedNCT03727802Phase 1Results posted
• A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT03725852Phase 2Results posted
• Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT03717012Phase 4Results posted
• A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of CareTerminatedNCT03711162Phase 3Results posted
• Investigating Trends in Quality of Life in Patients With Idiopathic Pulmonary Fibrosis (IPF) Under Treatment With NintedanibCompletedNCT03710824Results posted
• Families-At-risk for Interstitial Lung Disease StudyCompletedNCT03641742Results posted
• An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary FibrosisTerminatedNCT03573505Phase 2Results posted
• Telenursing and Remote Monitoring in Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT03562247Not applicableResults posted
• JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPFCompletedNCT03538301Phase 2Results posted
• Digital Auscultation Test - IPF Data CollectionCompletedNCT03503188Phase 4Results posted
• OASIS-IPF (Idiopathic Pulmonary Fibrosis) StudyCompletedNCT03386994Results posted
• Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary FibrosisTerminatedNCT03287414Phase 2Results posted
• Chart Review Study to Describe the Clinical Profile of Idiopathic Pulmonary Fibrosis (IPF) Patients Treated With Nintedanib (OFEV®) in Real-world Practice in SpainCompletedNCT03281200Results posted
• A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic PeriodCompletedNCT03261037Not applicableResults posted
• Non-Interventional Study (NIS) Collecting Experiences For IPF in TaiwanCompletedNCT03242759Results posted
• Open-label Study to Assess the Effectiveness of Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (IPF).CompletedNCT03208933Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary FibrosisTerminatedNCT03142191Phase 2Results posted
• Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary FibrosisCompletedNCT03104322Not applicableResults posted
• Investigating Idiopathic Pulmonary Fibrosis in GreeceCompletedNCT03074149Results posted
• Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) ImagingTerminatedNCT03069989Phase 1Results posted
• Post Marketing Surveillance of Nintedanib in Indian Patients With Idiopathic Pulmonary FibrosisCompletedNCT03047031Results posted
• Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at RestTerminatedNCT02989168Phase 2Results posted
• Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary HypertensionCompletedNCT02951429Phase 2Results posted
• A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT02871401Phase 1Results posted
• Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPFCompletedNCT02846324Phase 2Results posted
• IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary FibrosisCompletedNCT02803580Results posted
• Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function ImpairmentCompletedNCT02802345Phase 3Results posted
• Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity ImpairmentCompletedNCT02788474Phase 4Results posted
• CleanUP IPF for the Pulmonary Trials CooperativeTerminatedNCT02759120Phase 3Results posted
• Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT02738801Phase 2Results posted
• Advancing Symptom Alleviation With Palliative TreatmentCompletedNCT02713347Not applicableResults posted
• A Study to Assess the Safety and Tolerability of N-Acetylcysteine When Administered With Pirfenidone to Participants With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT02707640Phase 2Results posted
• A 2-Part, Phase 2 Open-label and Crossover Study of Belumosudil for Treatment of Idiopathic Pulmonary FibrosisCompletedNCT02688647Phase 2Results posted
• An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFETerminatedNCT02633293Phase 2/3Results posted
• Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFECompletedNCT02630316Phase 2/3Results posted
• All-Case Surveillance of Ofev in Patients With IPF in JapanCompletedNCT02607722Results posted
• A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in CombinationCompletedNCT02606877Phase 4Results posted
• Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT02598193Phase 4Results posted
• Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPFCompletedNCT02579603Phase 4Results posted
• A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT02550873Phase 2Results posted
• A Study of Gefapixant (AF-219/MK-7264) in Participants With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough (MK-7264-016)CompletedNCT02502097Phase 2Results posted
• A Study to Assess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT02477709Phase 2Results posted
• Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis PatientsCompletedNCT02421120Phase 4Results posted
• Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary FibrosisCompletedNCT02370693Phase 2Results posted
• Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary FibrosisCompletedNCT02345070Phase 2Results posted
• RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF PatientsCompletedNCT02257177Phase 1/2Results posted
• Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)TerminatedNCT02138825Phase 2Results posted
• Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIATCompletedNCT02036970Phase 2Results posted
• D2212C00002 J-Phase II StudyCompletedNCT02036580Phase 2Results posted

← Pulmonary Fibrosis overview